Company profile: Farmalider
1.1 - Company Overview
Company description
- Provider of development, registration, licensing and manufacturing of generic pharmaceuticals, with two plants producing prescription, OTC and dietary supplement products in liquid, granulated and solid oral forms. Specializes in pain management, leading in ibuprofen and paracetamol in Spain. Services include formulation R&D, clinical trial batches, registration documentation, pharmacovigilance, and supply of generics in growing European markets.
Products and services
- Generic Medications: Licenses and supplies commercial-grade generic products, specializing in pain management with market-leading ibuprofen and paracetamol in Spain and a growing presence across European markets supporting sustainable healthcare
- Pharmaceutical Manufacturing: Operates two industrial-scale plants producing pharmaceuticals and dietary supplements, specializing in liquid and granulated products plus solid oral forms
- Pharmaceutical Product Development: Architects regulatory-grade formulation programs, conducting research, development, scale-up, and clinical-trial batch production with complete registration documentation to support licensing
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to Farmalider
Solve Therapeutics
HQ: United States
Website
- Description: Provider of biopharmaceutical therapies developing antibody-drug conjugates and bispecific therapeutics.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Solve Therapeutics company profile →
Anji Pharma
HQ: United States
Website
- Description: Provider of therapeutics targeting high-value, human genetics-validated targets, including ANJ900, a gut-targeted formulation of metformin for type 2 diabetes patients with advanced chronic kidney disease to lower glucose with reduced systemic exposure, and ANJ908 (Pradigastat), a DGAT1 inhibitor for chronic idiopathic constipation to increase bowel movement frequency and soften stool.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Anji Pharma company profile →
Questcor Pharmaceuticals
HQ: United States
Website
- Description: Provider of biopharmaceutical treatments for serious, difficult-to-treat autoimmune and inflammatory disorders, focused on neurology and nephrology, and supporting research efforts in a variety of conditions.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Questcor Pharmaceuticals company profile →
Rosemont Pharmaceuticals
HQ: United Kingdom
Website
- Description: Provider of oral liquid medicines for patients with swallowing difficulties, manufacturing and supplying 130+ formulations across therapeutic categories. Offers R&D for new low-excipient liquid medications, GMP and ICH Q10-compliant, regularly inspected manufacturing, international distribution to 27+ markets, and educational resources for healthcare professionals.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Rosemont Pharmaceuticals company profile →
Navamedic
HQ: Sweden
Website
- Description: Provider of pharmaceutical and medtech products, marketing to patients, hospitals and pharmacies. Offers prescription and OTC medicines and healthcare products; the Sippi next-generation digital urine meter; and a portfolio including Eroxon gel to help men achieve an erection, Flexilev for Parkinson’s, Absolut Torr antiperspirant, MedMade micronutrient supplements, and PKU and obesity education/support programs.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Navamedic company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for Farmalider
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to Farmalider
2.2 - Growth funds investing in similar companies to Farmalider
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for Farmalider
4.2 - Public trading comparable groups for Farmalider
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →